Thursday, February 08, 2018 7:24:45 AM
Recent GENE News
- Genetic Technologies Announces $2 Million Registered Direct Offering • GlobeNewswire Inc. • 04/18/2024 04:17:51 PM
- New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes • GlobeNewswire Inc. • 04/17/2024 12:00:00 PM
- GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- GTG to pilot GeneType in Breast Screen centers across the U.S. • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk” • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market • GlobeNewswire Inc. • 04/02/2024 12:05:00 PM
- GTG Global Collaborations and Innovation Update • GlobeNewswire Inc. • 03/26/2024 12:00:00 PM
- GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/26/2024 01:00:38 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/15/2024 01:00:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:14:47 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/31/2024 01:00:25 PM
- Launching our most comprehensive test and expanding into new global markets • GlobeNewswire Inc. • 01/31/2024 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/09/2024 01:00:22 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/05/2024 01:00:16 PM
- Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 01/05/2024 01:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/05/2024 05:15:09 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/28/2023 01:00:23 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/27/2023 01:00:13 PM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 12/20/2023 10:00:51 PM
- GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness • GlobeNewswire Inc. • 12/14/2023 01:00:00 PM
- Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change • GlobeNewswire Inc. • 12/12/2023 01:00:00 PM
- Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial • GlobeNewswire Inc. • 10/30/2023 12:00:00 PM
- GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment • GlobeNewswire Inc. • 10/18/2023 12:30:00 PM
- GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network • GlobeNewswire Inc. • 09/27/2023 01:00:00 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM